- Global Pharma News & Resources

BioMarin to Participate in Cowen and Company 39th Annual Health Care Conference on March 12 in Boston

SAN RAFAEL, Calif., March 6, 2019 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), today announced that Jean-Jacques Bienaim√©, Chairman and Chief Executive Officer, will present at the Cowen and Company Health Care Conference on March 12 at 10:40am ET in Boston.  To access the live webcast, please visit the investor section of the BioMarin website, A replay will also be archived on the site for at least one week following each event.

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of seven commercialized products and multiple clinical and pre-clinical product candidates.  

For additional information, please visit Information on BioMarin's website is not incorporated by reference into this press release.




Traci McCarty

Debra Charlesworth

BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc.

(415) 455-7558

(415) 455-7451


View original content to download multimedia:

SOURCE BioMarin Pharmaceutical Inc.

Editor Details

Last Updated: 06-Mar-2019